Bruno Amato1, Tommaso Bianco1, Rita Compagna1, Maria Siano2, Giovanni Esposito3, Gianluca Buffone4, Raffaele Serra5, Stefano de Franciscis4. 1. Department of General, Geriatric, Oncologic Surgery and Advanced Technologies, University of Naples "Federico II," Naples, Italy. 2. Department of Pathology and Cytopathology, University of Naples "Federico II," Naples, Italy. 3. Department of Clinical Medicine and Cardiovascular and Immunological Sciences, University of Naples "Federico II," Naples, Italy. 4. Department of Medical and Surgical Science, University Magna Graecia of Catanzaro, Viale Europa, Località Germaneto 88100, Catanzaro, Italy. 5. Department of Medical and Surgical Science, University Magna Graecia of Catanzaro, Viale Europa, Località Germaneto 88100, Catanzaro, Italy. Electronic address: rserra@unicz.it.
Abstract
BACKGROUND: Carotid body tumors (CBTs) are relatively rare neoplasms, and even if they are considered predominantly benign, there is an indication for early surgical removal. The objective of this study was to conduct a review of the surgical management of CBTs. METHODS: A retrospective study identified 34 cases (12 men and 19 women) of tumors in patients who had undergone surgical resection of pathologically confirmed CBTs over a period of 10 years from 2001 to 2011 in 2 academic departments of general surgery in Italy. RESULTS: In our series, 10 CBTs (31%) were Shamblin class I, 13 (41%) were class II, and 9 tumors (27%) were class III. Two patients (6%) had transient cerebral ischemia immediately after operation. One patient (3%) died of postoperative cerebral ischemia after surgery for internal carotid artery thrombosis. CONCLUSIONS: The experience of this casuistry shows that the procedure is relatively low risk for Shamblin I and II classes, whereas there is an increasing risk of neurovascular complications for Shamblin III class.
BACKGROUND:Carotid body tumors (CBTs) are relatively rare neoplasms, and even if they are considered predominantly benign, there is an indication for early surgical removal. The objective of this study was to conduct a review of the surgical management of CBTs. METHODS: A retrospective study identified 34 cases (12 men and 19 women) of tumors in patients who had undergone surgical resection of pathologically confirmed CBTs over a period of 10 years from 2001 to 2011 in 2 academic departments of general surgery in Italy. RESULTS: In our series, 10 CBTs (31%) were Shamblin class I, 13 (41%) were class II, and 9 tumors (27%) were class III. Two patients (6%) had transient cerebral ischemia immediately after operation. One patient (3%) died of postoperative cerebral ischemia after surgery for internal carotid artery thrombosis. CONCLUSIONS: The experience of this casuistry shows that the procedure is relatively low risk for Shamblin I and II classes, whereas there is an increasing risk of neurovascular complications for Shamblin III class.
Authors: David M Straughan; Vladimir K Neychev; Samira M Sadowski; Ryan J Ellis; Francine Thomas; Nicholas J Patronas; Karel Pacak; Electron Kebebew; Naris Nilubol Journal: World J Surg Date: 2015-08 Impact factor: 3.352
Authors: Barbara Peric; Ziva Pohar Marinsek; Breda Skrbinc; Maja Music; Ivana Zagar; Marko Hocevar Journal: World J Surg Oncol Date: 2014-08-20 Impact factor: 2.754
Authors: Diego José Rojas Esquivel; Stefan Stefanov Kiuri; Alvaro Fernández Heredero; Luis Riera De Cubas; José Cebrian Carretero Journal: SAGE Open Med Case Rep Date: 2014-11-19
Authors: Antonio Romeo; Giuseppina Napolitano; Giuseppe Leone; Alessandra Aiello; Antonietta La Porta; Enrico Tedeschi; Francesco Briganti; Ferdinando Caranci Journal: Open Med (Wars) Date: 2016-08-12